nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—ovarian cancer	0.476	1	CbGaD
Sodium stibogluconate—TOP1—Topotecan—ovarian cancer	0.438	1	CbGbCtD
Sodium stibogluconate—TOP1—myometrium—ovarian cancer	0.00272	0.159	CbGeAlD
Sodium stibogluconate—TOP1—uterine cervix—ovarian cancer	0.00211	0.124	CbGeAlD
Sodium stibogluconate—TOP1—decidua—ovarian cancer	0.00201	0.118	CbGeAlD
Sodium stibogluconate—TOP1—endometrium—ovarian cancer	0.00191	0.112	CbGeAlD
Sodium stibogluconate—TOP1—uterus—ovarian cancer	0.00176	0.103	CbGeAlD
Sodium stibogluconate—TOP1—bone marrow—ovarian cancer	0.00149	0.0875	CbGeAlD
Sodium stibogluconate—TOP1—female gonad—ovarian cancer	0.00144	0.0843	CbGeAlD
Sodium stibogluconate—TOP1—vagina—ovarian cancer	0.00143	0.0838	CbGeAlD
Sodium stibogluconate—TOP1—testis—ovarian cancer	0.00128	0.0748	CbGeAlD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—XIAP—ovarian cancer	0.0012	0.109	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—PARP1—ovarian cancer	0.000991	0.0906	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNFSF10—ovarian cancer	0.000979	0.0895	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000971	0.0887	CbGpPWpGaD
Sodium stibogluconate—TOP1—lymph node—ovarian cancer	0.000926	0.0542	CbGeAlD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000664	0.0607	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—HNF1B—ovarian cancer	0.000576	0.0526	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP3—ovarian cancer	0.000379	0.0347	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000378	0.0346	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000346	0.0316	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000324	0.0296	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000293	0.0268	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000284	0.0259	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000284	0.0259	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000279	0.0255	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TYMS—ovarian cancer	0.000268	0.0244	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000216	0.0198	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—AKT1—ovarian cancer	0.000205	0.0188	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000205	0.0187	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000159	0.0145	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000147	0.0134	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000144	0.0132	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00014	0.0128	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000139	0.0127	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000135	0.0124	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PTEN—ovarian cancer	0.00013	0.0119	CbGpPWpGaD
Sodium stibogluconate—Dyspnoea—Topotecan—ovarian cancer	0.000129	0.00224	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000129	0.00224	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Chlorambucil—ovarian cancer	0.000129	0.00223	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Chlorambucil—ovarian cancer	0.000129	0.00223	CcSEcCtD
Sodium stibogluconate—Renal failure—Paclitaxel—ovarian cancer	0.000128	0.00223	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Paclitaxel—ovarian cancer	0.000128	0.00222	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Melphalan—ovarian cancer	0.000127	0.00221	CcSEcCtD
Sodium stibogluconate—Fluid retention—Epirubicin—ovarian cancer	0.000127	0.0022	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Melphalan—ovarian cancer	0.000126	0.00219	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Epirubicin—ovarian cancer	0.000126	0.00219	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Topotecan—ovarian cancer	0.000126	0.00219	CcSEcCtD
Sodium stibogluconate—Fatigue—Topotecan—ovarian cancer	0.000125	0.00217	CcSEcCtD
Sodium stibogluconate—Dysphagia—Docetaxel—ovarian cancer	0.000124	0.00216	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000124	0.00215	CcSEcCtD
Sodium stibogluconate—Constipation—Topotecan—ovarian cancer	0.000124	0.00215	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Melphalan—ovarian cancer	0.000123	0.00214	CcSEcCtD
Sodium stibogluconate—Infection—Vinorelbine—ovarian cancer	0.000123	0.00214	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000122	0.0112	CbGpPWpGaD
Sodium stibogluconate—Fatigue—Melphalan—ovarian cancer	0.000122	0.00212	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Docetaxel—ovarian cancer	0.000122	0.00212	CcSEcCtD
Sodium stibogluconate—Tachycardia—Vinorelbine—ovarian cancer	0.000121	0.0021	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00012	0.00208	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Topotecan—ovarian cancer	0.000118	0.00206	CcSEcCtD
Sodium stibogluconate—Anorexia—Vinorelbine—ovarian cancer	0.000118	0.00205	CcSEcCtD
Sodium stibogluconate—Fluid retention—Doxorubicin—ovarian cancer	0.000117	0.00204	CcSEcCtD
Sodium stibogluconate—Asthenia—Chlorambucil—ovarian cancer	0.000117	0.00203	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000117	0.00203	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Doxorubicin—ovarian cancer	0.000117	0.00203	CcSEcCtD
Sodium stibogluconate—Sepsis—Epirubicin—ovarian cancer	0.000116	0.00201	CcSEcCtD
Sodium stibogluconate—Hypotension—Vinorelbine—ovarian cancer	0.000116	0.00201	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000116	0.0106	CbGpPWpGaD
Sodium stibogluconate—Pruritus—Chlorambucil—ovarian cancer	0.000115	0.002	CcSEcCtD
Sodium stibogluconate—Urticaria—Topotecan—ovarian cancer	0.000115	0.002	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Topotecan—ovarian cancer	0.000115	0.00199	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Topotecan—ovarian cancer	0.000115	0.00199	CcSEcCtD
Sodium stibogluconate—Urticaria—Melphalan—ovarian cancer	0.000113	0.00196	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000113	0.0103	CbGpPWpGaD
Sodium stibogluconate—Phlebitis—Epirubicin—ovarian cancer	0.000113	0.00195	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Chlorambucil—ovarian cancer	0.000111	0.00193	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Vinorelbine—ovarian cancer	0.000111	0.00193	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Vinorelbine—ovarian cancer	0.00011	0.00192	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.00011	0.0101	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.00011	0.0101	CbGpPWpGaD
Sodium stibogluconate—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000109	0.0019	CcSEcCtD
Sodium stibogluconate—Renal failure—Docetaxel—ovarian cancer	0.000109	0.00189	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Docetaxel—ovarian cancer	0.000109	0.00188	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Vinorelbine—ovarian cancer	0.000108	0.00187	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—ovarian cancer	0.000107	0.00186	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000107	0.00186	CcSEcCtD
Sodium stibogluconate—Fatigue—Vinorelbine—ovarian cancer	0.000107	0.00185	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Topotecan—ovarian cancer	0.000107	0.00185	CcSEcCtD
Sodium stibogluconate—Constipation—Vinorelbine—ovarian cancer	0.000106	0.00184	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—ovarian cancer	0.000105	0.00182	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Paclitaxel—ovarian cancer	0.000105	0.00182	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Melphalan—ovarian cancer	0.000104	0.00181	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—ovarian cancer	0.000104	0.00181	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000104	0.0095	CbGpPWpGaD
Sodium stibogluconate—Asthenia—Topotecan—ovarian cancer	0.000104	0.0018	CcSEcCtD
Sodium stibogluconate—Vomiting—Chlorambucil—ovarian cancer	0.000103	0.0018	CcSEcCtD
Sodium stibogluconate—Pruritus—Topotecan—ovarian cancer	0.000102	0.00178	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—ovarian cancer	0.000102	0.00177	CcSEcCtD
Sodium stibogluconate—Asthenia—Melphalan—ovarian cancer	0.000102	0.00177	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000101	0.00176	CcSEcCtD
Sodium stibogluconate—Flatulence—Paclitaxel—ovarian cancer	0.000101	0.00175	CcSEcCtD
Sodium stibogluconate—Pruritus—Melphalan—ovarian cancer	0.0001	0.00174	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Paclitaxel—ovarian cancer	0.0001	0.00174	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Topotecan—ovarian cancer	9.91e-05	0.00172	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Docetaxel—ovarian cancer	9.89e-05	0.00172	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—ovarian cancer	9.89e-05	0.00172	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—ovarian cancer	9.89e-05	0.00172	CcSEcCtD
Sodium stibogluconate—Urticaria—Vinorelbine—ovarian cancer	9.84e-05	0.00171	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Vinorelbine—ovarian cancer	9.8e-05	0.0017	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Vinorelbine—ovarian cancer	9.8e-05	0.0017	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—ovarian cancer	9.73e-05	0.00169	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—ovarian cancer	9.72e-05	0.00169	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Melphalan—ovarian cancer	9.7e-05	0.00168	CcSEcCtD
Sodium stibogluconate—Nausea—Chlorambucil—ovarian cancer	9.66e-05	0.00168	CcSEcCtD
Sodium stibogluconate—Vision blurred—Paclitaxel—ovarian cancer	9.62e-05	0.00167	CcSEcCtD
Sodium stibogluconate—Dizziness—Topotecan—ovarian cancer	9.58e-05	0.00166	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.55e-05	0.00873	CbGpPWpGaD
Sodium stibogluconate—Renal impairment—Doxorubicin—ovarian cancer	9.43e-05	0.00164	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.24e-05	0.00845	CbGpPWpGaD
Sodium stibogluconate—Vomiting—Topotecan—ovarian cancer	9.21e-05	0.0016	CcSEcCtD
Sodium stibogluconate—Syncope—Paclitaxel—ovarian cancer	9.16e-05	0.00159	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—ovarian cancer	9.15e-05	0.00159	CcSEcCtD
Sodium stibogluconate—Rash—Topotecan—ovarian cancer	9.13e-05	0.00159	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Vinorelbine—ovarian cancer	9.13e-05	0.00158	CcSEcCtD
Sodium stibogluconate—Dermatitis—Topotecan—ovarian cancer	9.12e-05	0.00158	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—ovarian cancer	9.08e-05	0.00158	CcSEcCtD
Sodium stibogluconate—Headache—Topotecan—ovarian cancer	9.07e-05	0.00158	CcSEcCtD
Sodium stibogluconate—Palpitations—Paclitaxel—ovarian cancer	9.02e-05	0.00157	CcSEcCtD
Sodium stibogluconate—Vomiting—Melphalan—ovarian cancer	9.02e-05	0.00157	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—ovarian cancer	9.02e-05	0.00156	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—ovarian cancer	9.01e-05	0.00156	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Paclitaxel—ovarian cancer	8.98e-05	0.00156	CcSEcCtD
Sodium stibogluconate—Rash—Melphalan—ovarian cancer	8.94e-05	0.00155	CcSEcCtD
Sodium stibogluconate—Dermatitis—Melphalan—ovarian cancer	8.93e-05	0.00155	CcSEcCtD
Sodium stibogluconate—Asthenia—Vinorelbine—ovarian cancer	8.89e-05	0.00154	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Docetaxel—ovarian cancer	8.88e-05	0.00154	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—ovarian cancer	8.87e-05	0.00811	CbGpPWpGaD
Sodium stibogluconate—Convulsion—Paclitaxel—ovarian cancer	8.85e-05	0.00154	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—ovarian cancer	8.82e-05	0.00153	CcSEcCtD
Sodium stibogluconate—Pruritus—Vinorelbine—ovarian cancer	8.77e-05	0.00152	CcSEcCtD
Sodium stibogluconate—Chest pain—Paclitaxel—ovarian cancer	8.69e-05	0.00151	CcSEcCtD
Sodium stibogluconate—Anxiety—Paclitaxel—ovarian cancer	8.66e-05	0.0015	CcSEcCtD
Sodium stibogluconate—Nausea—Topotecan—ovarian cancer	8.6e-05	0.00149	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vinorelbine—ovarian cancer	8.48e-05	0.00147	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Docetaxel—ovarian cancer	8.48e-05	0.00147	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—ovarian cancer	8.44e-05	0.00146	CcSEcCtD
Sodium stibogluconate—Nausea—Melphalan—ovarian cancer	8.42e-05	0.00146	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—ovarian cancer	8.4e-05	0.00146	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—ovarian cancer	8.38e-05	0.00145	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—ovarian cancer	8.34e-05	0.00145	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Paclitaxel—ovarian cancer	8.33e-05	0.00145	CcSEcCtD
Sodium stibogluconate—Oedema—Paclitaxel—ovarian cancer	8.33e-05	0.00145	CcSEcCtD
Sodium stibogluconate—Infection—Paclitaxel—ovarian cancer	8.28e-05	0.00144	CcSEcCtD
Sodium stibogluconate—Shock—Paclitaxel—ovarian cancer	8.2e-05	0.00142	CcSEcCtD
Sodium stibogluconate—Dizziness—Vinorelbine—ovarian cancer	8.19e-05	0.00142	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—ovarian cancer	8.16e-05	0.00142	CcSEcCtD
Sodium stibogluconate—Tachycardia—Paclitaxel—ovarian cancer	8.13e-05	0.00141	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—IL6—ovarian cancer	8.12e-05	0.00742	CbGpPWpGaD
Sodium stibogluconate—Bronchitis—Epirubicin—ovarian cancer	8.06e-05	0.0014	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Paclitaxel—ovarian cancer	8.06e-05	0.0014	CcSEcCtD
Sodium stibogluconate—Anorexia—Paclitaxel—ovarian cancer	7.94e-05	0.00138	CcSEcCtD
Sodium stibogluconate—Vomiting—Vinorelbine—ovarian cancer	7.88e-05	0.00137	CcSEcCtD
Sodium stibogluconate—Rash—Vinorelbine—ovarian cancer	7.81e-05	0.00136	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.81e-05	0.00713	CbGpPWpGaD
Sodium stibogluconate—Dermatitis—Vinorelbine—ovarian cancer	7.81e-05	0.00135	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—ovarian cancer	7.8e-05	0.00135	CcSEcCtD
Sodium stibogluconate—Hypotension—Paclitaxel—ovarian cancer	7.79e-05	0.00135	CcSEcCtD
Sodium stibogluconate—Headache—Vinorelbine—ovarian cancer	7.76e-05	0.00135	CcSEcCtD
Sodium stibogluconate—Syncope—Docetaxel—ovarian cancer	7.76e-05	0.00135	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—ovarian cancer	7.75e-05	0.00135	CcSEcCtD
Sodium stibogluconate—Palpitations—Docetaxel—ovarian cancer	7.65e-05	0.00133	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Docetaxel—ovarian cancer	7.61e-05	0.00132	CcSEcCtD
Sodium stibogluconate—Convulsion—Docetaxel—ovarian cancer	7.5e-05	0.0013	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Paclitaxel—ovarian cancer	7.48e-05	0.0013	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—ovarian cancer	7.46e-05	0.00129	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Paclitaxel—ovarian cancer	7.43e-05	0.00129	CcSEcCtD
Sodium stibogluconate—Chest pain—Docetaxel—ovarian cancer	7.37e-05	0.00128	CcSEcCtD
Sodium stibogluconate—Nausea—Vinorelbine—ovarian cancer	7.36e-05	0.00128	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—ovarian cancer	7.34e-05	0.00127	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Paclitaxel—ovarian cancer	7.25e-05	0.00126	CcSEcCtD
Sodium stibogluconate—Fatigue—Paclitaxel—ovarian cancer	7.19e-05	0.00125	CcSEcCtD
Sodium stibogluconate—Constipation—Paclitaxel—ovarian cancer	7.13e-05	0.00124	CcSEcCtD
Sodium stibogluconate—Oedema—Docetaxel—ovarian cancer	7.06e-05	0.00123	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Docetaxel—ovarian cancer	7.06e-05	0.00123	CcSEcCtD
Sodium stibogluconate—Infection—Docetaxel—ovarian cancer	7.02e-05	0.00122	CcSEcCtD
Sodium stibogluconate—Shock—Docetaxel—ovarian cancer	6.95e-05	0.00121	CcSEcCtD
Sodium stibogluconate—Tachycardia—Docetaxel—ovarian cancer	6.89e-05	0.0012	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.82e-05	0.00118	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—ovarian cancer	6.8e-05	0.00118	CcSEcCtD
Sodium stibogluconate—Anorexia—Docetaxel—ovarian cancer	6.73e-05	0.00117	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—ovarian cancer	6.67e-05	0.00116	CcSEcCtD
Sodium stibogluconate—Urticaria—Paclitaxel—ovarian cancer	6.62e-05	0.00115	CcSEcCtD
Sodium stibogluconate—Hypotension—Docetaxel—ovarian cancer	6.6e-05	0.00115	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Paclitaxel—ovarian cancer	6.59e-05	0.00114	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Paclitaxel—ovarian cancer	6.59e-05	0.00114	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Docetaxel—ovarian cancer	6.34e-05	0.0011	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Docetaxel—ovarian cancer	6.3e-05	0.00109	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—ovarian cancer	6.17e-05	0.00107	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Docetaxel—ovarian cancer	6.14e-05	0.00107	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Paclitaxel—ovarian cancer	6.14e-05	0.00107	CcSEcCtD
Sodium stibogluconate—Fatigue—Docetaxel—ovarian cancer	6.09e-05	0.00106	CcSEcCtD
Sodium stibogluconate—Constipation—Docetaxel—ovarian cancer	6.04e-05	0.00105	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—ovarian cancer	5.99e-05	0.00104	CcSEcCtD
Sodium stibogluconate—Asthenia—Paclitaxel—ovarian cancer	5.98e-05	0.00104	CcSEcCtD
Sodium stibogluconate—Pruritus—Paclitaxel—ovarian cancer	5.9e-05	0.00102	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Docetaxel—ovarian cancer	5.78e-05	0.001	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—ovarian cancer	5.75e-05	0.000999	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—ovarian cancer	5.72e-05	0.000992	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Paclitaxel—ovarian cancer	5.7e-05	0.00099	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Docetaxel—ovarian cancer	5.58e-05	0.000969	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Docetaxel—ovarian cancer	5.58e-05	0.000969	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—ovarian cancer	5.54e-05	0.000962	CcSEcCtD
Sodium stibogluconate—Dizziness—Paclitaxel—ovarian cancer	5.51e-05	0.000957	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—ovarian cancer	5.5e-05	0.000955	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—ovarian cancer	5.32e-05	0.000924	CcSEcCtD
Sodium stibogluconate—Vomiting—Paclitaxel—ovarian cancer	5.3e-05	0.00092	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—ovarian cancer	5.29e-05	0.000918	CcSEcCtD
Sodium stibogluconate—Rash—Paclitaxel—ovarian cancer	5.26e-05	0.000912	CcSEcCtD
Sodium stibogluconate—Dermatitis—Paclitaxel—ovarian cancer	5.25e-05	0.000911	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—ovarian cancer	5.24e-05	0.000909	CcSEcCtD
Sodium stibogluconate—Headache—Paclitaxel—ovarian cancer	5.22e-05	0.000906	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Docetaxel—ovarian cancer	5.2e-05	0.000903	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—ovarian cancer	5.16e-05	0.000896	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—ovarian cancer	5.13e-05	0.000891	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—ovarian cancer	5.09e-05	0.000884	CcSEcCtD
Sodium stibogluconate—Asthenia—Docetaxel—ovarian cancer	5.07e-05	0.00088	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—ovarian cancer	5.06e-05	0.000878	CcSEcCtD
Sodium stibogluconate—Pruritus—Docetaxel—ovarian cancer	5e-05	0.000868	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—ovarian cancer	4.97e-05	0.000863	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—ovarian cancer	4.95e-05	0.00086	CcSEcCtD
Sodium stibogluconate—Nausea—Paclitaxel—ovarian cancer	4.95e-05	0.000859	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—ovarian cancer	4.84e-05	0.000841	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Docetaxel—ovarian cancer	4.83e-05	0.000839	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—ovarian cancer	4.77e-05	0.000829	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—ovarian cancer	4.76e-05	0.000827	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—ovarian cancer	4.76e-05	0.000827	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—ovarian cancer	4.75e-05	0.000824	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—ovarian cancer	4.73e-05	0.000822	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—ovarian cancer	4.69e-05	0.000814	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—ovarian cancer	4.68e-05	0.000812	CcSEcCtD
Sodium stibogluconate—Dizziness—Docetaxel—ovarian cancer	4.67e-05	0.000811	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—ovarian cancer	4.65e-05	0.000807	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—ovarian cancer	4.61e-05	0.0008	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—ovarian cancer	4.6e-05	0.000798	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—ovarian cancer	4.58e-05	0.000796	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—ovarian cancer	4.54e-05	0.000788	CcSEcCtD
Sodium stibogluconate—Vomiting—Docetaxel—ovarian cancer	4.49e-05	0.00078	CcSEcCtD
Sodium stibogluconate—Rash—Docetaxel—ovarian cancer	4.45e-05	0.000773	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—ovarian cancer	4.45e-05	0.000773	CcSEcCtD
Sodium stibogluconate—Dermatitis—Docetaxel—ovarian cancer	4.45e-05	0.000772	CcSEcCtD
Sodium stibogluconate—Headache—Docetaxel—ovarian cancer	4.43e-05	0.000768	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—ovarian cancer	4.41e-05	0.000765	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—ovarian cancer	4.41e-05	0.000765	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—ovarian cancer	4.38e-05	0.00076	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—ovarian cancer	4.34e-05	0.000753	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—ovarian cancer	4.3e-05	0.000747	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—ovarian cancer	4.28e-05	0.000743	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—ovarian cancer	4.26e-05	0.00074	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—ovarian cancer	4.25e-05	0.000737	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—ovarian cancer	4.2e-05	0.000729	CcSEcCtD
Sodium stibogluconate—Nausea—Docetaxel—ovarian cancer	4.2e-05	0.000728	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—ovarian cancer	4.14e-05	0.000719	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—ovarian cancer	4.12e-05	0.000715	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—ovarian cancer	4.11e-05	0.000713	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—ovarian cancer	4.07e-05	0.000707	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—ovarian cancer	3.96e-05	0.000687	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—ovarian cancer	3.93e-05	0.000682	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—ovarian cancer	3.9e-05	0.000676	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—ovarian cancer	3.83e-05	0.000665	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—ovarian cancer	3.8e-05	0.00066	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—ovarian cancer	3.79e-05	0.000657	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—ovarian cancer	3.77e-05	0.000654	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—ovarian cancer	3.77e-05	0.000654	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—ovarian cancer	3.77e-05	0.000654	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.61e-05	0.000626	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—ovarian cancer	3.51e-05	0.000609	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—ovarian cancer	3.5e-05	0.000608	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—ovarian cancer	3.49e-05	0.000605	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—ovarian cancer	3.49e-05	0.000605	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—ovarian cancer	3.42e-05	0.000593	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—ovarian cancer	3.37e-05	0.000585	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—ovarian cancer	3.26e-05	0.000566	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—ovarian cancer	3.25e-05	0.000564	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—ovarian cancer	3.16e-05	0.000549	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—ovarian cancer	3.15e-05	0.000547	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—ovarian cancer	3.12e-05	0.000541	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—ovarian cancer	3.03e-05	0.000526	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—ovarian cancer	3.02e-05	0.000524	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—ovarian cancer	3e-05	0.000521	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—ovarian cancer	3e-05	0.000521	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—ovarian cancer	2.99e-05	0.000518	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—ovarian cancer	2.92e-05	0.000506	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—ovarian cancer	2.83e-05	0.000491	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—ovarian cancer	2.8e-05	0.000487	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—ovarian cancer	2.78e-05	0.000483	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—ovarian cancer	2.78e-05	0.000482	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—ovarian cancer	2.76e-05	0.000479	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—ovarian cancer	2.62e-05	0.000455	CcSEcCtD
